Rectum cancers: New standard of preoperative chemoradiotheraphy;Cancers du rectum: La chimioradiothérapie préopé ratoire, nouveau standard

Cancer/Radiotherapie

Volumn 9, Issue 3, 2005, Pages 137-139

  Bosset, J F ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; DIARRHEA; EDITORIAL; HUMAN; INTESTINE STENOSIS; METASTASIS; PRIORITY JOURNAL; RADIATION INJURY; RECTUM CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; HUMANS; NEOADJUVANT THERAPY; RECTAL NEOPLASMS;

EID: 22144482337     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2005.05.005     Document Type: Editorial

References (21)

1. T. Andre, C. Boni, L. Mounedji-Boudiaf, M. Navarro, J. Tabernero, and T. Hickish Oxaliplatin, fluorouracil and leucovorin as adjuvant treatment for colon cancer N. Engl. J. Med. 350 2004 2343 2351
2. R.G.H. Beets-Tan, G.L. Beets, R.F.A. Vliegen, A.G.H. Kessels, H. Van Boven, and A. De Bruine Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery Lancet 357 2001 497 504
3. J.F. Bosset, G. Calais, L. Mineur, P. Maingon, L. Radosevic-Jelic, and A. Daban Enhanced tumorocidal effect of preoperative radiotherapy on rectal cancer by adding chemotherapy: preliminary results from the 22921 EORTC randomised trial J. Clin. Oncol. 2005 (̀ paràtre)
4. J.F. Bosset, G. Calais, L. Mineur, P. Maingon, L. Radosevic-Jelic, and A. Daban Preoperative radiation (preop RT) in rectal cancer: effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial J. Clin. Oncol. 23 2005 247s
5. J.F. Bosset, G. Mantion, F. Lorchel, V. Magnin, E. Pelissier, and J.P. Gerard Adjuvant and neoadjuvant radiation therapy for rectal cancer Semin. Oncol. 27 2000 60 65
6. J.F. Bosset, J.J. Pavy, H.P. Hamers, J.C. Horiot, M.C. Fabri, and P. Rougier Determination of the optimal dose of 5-Fluorouracil when combined with low dose D, L-Leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies Eur. J. Cancer 29A 1993 1406 1410
7. J. Cassidy, W. Scheithauer, and J. mcKendrick Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): positive efficacy results of a phase III trial J. Clin. Oncol. 23 2004 2475
8. C.H. Crane, and D.J. Sargent Substitution of oral fluoropyrimidines for infusional fluorouracil with radiotherapy: how much data do we need? J. Clin. Oncol. 22 2004 2978 2981
9. S. Galandiuk, H.S. Wieand, C.G. Moertel, S.S. Cha, R.J. Fitzgibbons, and J.H. Pemberton Patterns of recurrence after curative resection of carcinoma of the colon and rectum Surg. Gynecol. Obstet. 174 1992 227 232
10. J.P. Gerard, F. Bonnetain, T. Conroy, O. Chapet, O. Bouche, and M.T. Closon-Dejardin Preoperative (preop) radiotherapy (RT) ± 5-FU/folinic acid (FA) in T3-4 rectal cancers: results of the FFCD 9203 randomized trial J. Clin. Oncol. 23 2005 247s
11. R.J. Heald, E.M. Husband, and R.D. Ryall The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br. J. Surg. 69 1982 613 616
12. E. Kapiteijn, C.A.M. Marijnen, I.D. Nagtegaal, H. Putter, W.H. Steup, and T. Wiggers Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N. Engl. J. Med. 345 2001 638 646
13. A.L. Martling, T. Holm, L.E. Rutqvist, B.J. Moran, R.J. Heald, and B. Cedermark Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm Lancet 356 2000 93 96
14. National institute of health consensus conference: adjuvant therapy for patients with colon and rectal cancer JAMA 264 1990 1444 1449
15. J. Papillon The future of external beam irradiation as initial treatment of rectal cancer Br. J. Surg. 74 1987 449 454
16. R. Raab, H.J. Meyer, and U. Werner Surgery for rectal cancer H. Bleiberg N. Kemeny P. Rougier H. Wilke Colorectal cancer. A clinical guide to therapy 2002 Martin Dunitz Ltd Londres 173 184
17. C. Rödel, G.G. Grabenbauer, T. Papadopoulos, W. Hohenberger, H.J. Schmoll, and R. Sauer Phase I/II trial of capecitabline, oxaliplatin, and radiation for rectal cancer J. Clin. Oncol. 21 2003 3098 3104
18. R. Sauer, H. Becker, W. Hohenberger, C. Rödel, C. Wittekind, and R. Fietkau Preoperative versus postoperative chemoradiotherapy for rectal cancer N. Engl. J. Med. 351 2004 1731 1740
19. N. Sawada, T. Ishikawa, F. Sekiguchi, Y. Tanaka, and H. Ishitsuka X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts Clin. Cancer Res. 5 1999 2948 2953
20. C.J.H. Van de Velde Rectal cancer value of adjuvant treatment in relation to TME surgery Fifth international congress: perspectives in colorectal cancer 2003 Imedex
21. A. Wilbe, B. Moller, J. Norstein, E. Carlsen, J.N. Wiig, and R.J. Heald A national strategic change in treatment policy for rectal cancer -:implementation of total mesorectal excision as routine treatment in Norway. A national audit Dis. Colon Rectum 45 2002 857 866